Saturday, July 4, 2026

Biosimilar Red Tape Showdown: Patient Groups and Insurers Push Congress to End “Interchangeability” Rules After $56B in Savings

U.S. groups urge Congress to eliminate biosimilar interchangeability regulations, boosting access and reducing costs for Korean firms.

New Breakthrough: HER2 Positive Stomach Cancer Treatment with Dual Targeted Therapy Shows 81% Tumor Size Reduction

A study reveals that combining trastuzumab deruxtecan and pertuzumab significantly reduces tumor size in HER2-positive gastric cancer.

SK Hynix Surpasses Samsung to Lead Global Memory Market for First Time

SK Hynix surpasses Samsung in global memory sales for Q2, with a significant rise in HBM market share amid Samsung's struggles.

Tag: small firms

How Will Korea’s New R&D-Linked Drug Pricing Impact the Pharma Industry in 2026?

The new drug pricing reform aims to boost R&D in the pharmaceutical industry, but raises concerns for smaller firms facing cash flow issues.

Top News

- Our Sponsors Ad -

Follow us